Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04577976 · ClinicalTrials.gov registry record
FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pediatric Patients - BG
A clinical trial, sponsored by Abbott Diabetes Care.
- Terminated
- Registry status
- 62
- Enrollment target
NCT04577976: Clinical Trial study, sponsored by Abbott Diabetes Care.
NCT04577976 is a clinical trial that was terminated before completion, run by Abbott Diabetes Care. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04577976 was terminated before completion, sponsored by Abbott Diabetes Care.
- TERMINATED
- Registry status
- 62 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, non-randomized, single-arm study intended to characterize the safety of self-monitoring of blood glucose (SMBG) when used to manage diabetes in pediatric patients.
Primary Outcome
Rate of Serious Adverse events associated with Hypoglycemia and Hyper glycaemia will be determined. (e.g severe hypoglycemic occurrences requiring health care professional (HCP) intervention including EMT assistance, hospital/clinic visit and/or hospitalization and moderate hypoglycemia in which the patient required the assistance of another person \[e.g. as a result of confusion, coma, or seizure\] during the study.
Interventions
- DEVICE SMBG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2020-09-23 |
| Est. Completion | 2022-07-14 |
Why NCT04577976 stopped before completion
NCT04577976 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which SMBG is the first listed.
NCT04577976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04577976 about?
NCT04577976 is a clinical study titled "FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pediatric Patients - BG". This is a prospective, multi-center, non-randomized, single-arm study intended to characterize the safety of self-monitoring of blood glucose (SMBG) when used to manage diabetes in pediatric patients.
What is the current status of trial NCT04577976?
This trial is currently terminated. The enrollment target is 62 participants. The study started on 2020-09-23. Estimated completion is 2022-07-14.
What interventions are being tested in trial NCT04577976?
The interventions under investigation include: SMBG (DEVICE).
Who is sponsoring clinical trial NCT04577976?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI